Terumo Corporation (TYO:4543)

Terumo Financials Overview

Financials in millions JPY. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	1,183,722	1,131,877	1,036,171	921,863	820,209	703,303
Revenue Growth	14.04%	9.24%	12.40%	12.39%	16.62%	14.57%
Gross Profit Gross Profit Growth	629,986	596,914	560,670	481,035	417,370	369,341
Operating Income Operating Income Growth	231,105	197,509	182,917	140,560	123,861	116,664
Net Income Net Income Growth	164,497	135,914	116,978	106,374	89,325	88,813
Earnings Per Share EPS Growth	111.49	92.12	78.99	71.47	59.48	58.69
EPS Growth	31.95%	16.62%	10.52%	20.16%	1.35%	14.95%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cardiac and Vascular Company Cardiac and Vascular Company Growth	676,421	676,421	624,357	555,716	480,610	397,130
Medical Care Solutions Company Medical Care Solutions Company Growth	216,138	216,138	211,235	197,569	191,749	185,335
Blood and Cell Technologies Company Blood and Cell Technologies Company Growth	231,037	231,037	200,280	168,328	147,605	120,586
Terumo Organ Technologies Terumo Organ Technologies Growth	-	7,985	-	-	-	-
Adjustments Adjustments Growth	294	294	298	248	243	251

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	314,633	280,606	222,205	206,354	187,384	205,251
Total Debt Total Debt Growth	438,055	427,305	213,959	268,548	266,667	259,008
Net Cash (Debt) Net Cash Growth	-123,422	-146,699	8,246	-62,194	-79,283	-53,757
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-83.65	-99.43	5.57	-41.79	-52.79	-35.52

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	272,691	230,852	210,802	146,330	117,536	141,467
Capital Expenditures CapEx Growth	-80,827	-85,213	-68,617	-60,727	-52,697	-53,515
Free Cash Flow Free Cash Flow Growth	191,864	145,639	142,185	85,603	64,839	87,952
Free Cash Flow Growth	39.65%	2.43%	66.10%	32.02%	-26.28%	48.65%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	53.22%	52.74%	54.11%	52.18%	50.89%	52.52%
Operating Margin	19.52%	17.45%	17.65%	15.25%	15.10%	16.59%
Pretax Margin	18.02%	15.75%	14.92%	15.28%	14.16%	16.28%
Profit Margin	13.90%	12.01%	11.29%	11.54%	10.89%	12.63%
FCF Margin	16.21%	12.87%	13.72%	9.29%	7.90%	12.51%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	36.000	30.000	26.000	22.000	20.000	17.000
Dividend Per Share Growth	17.86%	15.38%	18.18%	10.00%	17.65%	17.24%
Dividend Yield	1.35%	1.42%	0.94%	0.83%	1.16%	0.95%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 15, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	23.97	22.88	35.27	38.09	29.79	31.71
Forward PE	20.81	20.36	28.78	33.65	24.71	28.85
P/FCF Ratio	20.55	21.35	29.01	47.33	41.04	32.02
PS Ratio	3.33	2.75	3.98	4.39	3.25	4.01

Data Sources: S&P Global Market Intelligence and Fiscal.ai Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company. Revenue segment data is provided by Fiscal.ai.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error